Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

NCT05120726 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT05120726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Therapeutic Treatment of Pyoderma Gangrenosum
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Phase 4
Overall status
Terminated
Start date
June 2, 2021
Completion date
November 18, 2024
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma gangrenosum